BCP upon oral administration appears to alleviate hyperglycemia and protect β-cells by increasing insulin release and preventing oxidative stress and inflammatory cytokines in pancreas and plasma of diabetic rats [29]. This evidence concerns the gene INS and Hyperglycemia.